Skip to content
NASDAQ · PHARMACEUTICAL PREPARATIONS · LARGE CAP

Praxis Precision Medicines, Inc. PRAX

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$0
▼ 100.0% YoY
$-303.3M
$-249.1M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 0.00
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.0 · Net income -303.3
-150M-300M
201920222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2024 · Operating -2340.3%
-2000%-4000%
201920222025
ROE
FY2025 · ROE -45.8%
-50%-100%-150%
201920222025
Three returns, three denominators.

Each USD of equity lost 46 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -249.1
-100M-200M
201920222025

Total assetsUSD 937.9M
EquityUSD 878.1M
CashUSD 357.3M
Current ratio10.22×

Equity funds 94% of total assets.

The 7-year record

7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
PRAX, 7-year financial record
Metric 2025202420232022202120202019
Revenue $B0.00.00.00.0◌◌◌
Operating income $B−0.3−0.2−0.1−0.2−0.2−0.1−0.0
EBITDA $B−0.3−0.2−0.1−0.2−0.2−0.1−0.0
Income tax $B0.0◌◌◌0.0−0.0−0.0
Net income $B−0.3−0.2−0.1−0.2−0.2−0.1−0.0
Free cash flow $B−0.2−0.1−0.1−0.2−0.1−0.1−0.0
EPS, diluted $−13.48−10.21−18.69−69.65−3.94−7.86−26.60
Dividend / sh $◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————
ROE %−45.8−71.0−169.1−130.9−62.1——
Shares out B0.030.020.010.050.050.040.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 28 reconciliationsAUDITED

Reconciled in 7 of the 7 fiscal years we could check. 24 checks were skipped: the balance sheet is not tagged before 2019. 12 checks were skipped: EPS is not tagged before 2019.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image